BAMCO INC /NY/ - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 192 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.40 and the average weighting 0.3%.

Quarter-by-quarter ownership
BAMCO INC /NY/ ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$3,450,000
+53.9%
72,334
+47.2%
0.02%
+50.0%
Q1 2017$2,241,000
+186.2%
49,134
+102.6%
0.01%
+200.0%
Q4 2016$783,000
+4.4%
24,255
+10.6%
0.00%0.0%
Q3 2016$750,000
-60.5%
21,921
-61.1%
0.00%
-60.0%
Q2 2016$1,901,000
+121.3%
56,351
+247.6%
0.01%
+100.0%
Q1 2016$859,000
-13.4%
16,211
+25.4%
0.01%0.0%
Q4 2015$992,000
+249.3%
12,923
+87.3%
0.01%
+400.0%
Q3 2015$284,000
-96.1%
6,900
-91.6%
0.00%
-96.4%
Q1 2015$7,319,000
+23.0%
82,380
+22.8%
0.03%
+16.7%
Q4 2014$5,948,000
-1.2%
67,088
+8.0%
0.02%
-4.0%
Q3 2014$6,023,000
-57.5%
62,139
-59.8%
0.02%
-55.4%
Q2 2014$14,183,000
+1084.9%
154,393
+802.9%
0.06%
+1020.0%
Q1 2014$1,197,000
+220.9%
17,100
+163.3%
0.01%
+150.0%
Q4 2013$373,0006,4950.00%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Tamarack Advisers, LP 360,000$21,845,0006.19%
Gagnon Advisors, LLC 213,217$12,938,0004.92%
GAGNON SECURITIES LLC 499,333$30,300,0004.30%
Spyglass Capital Management LLC 2,117,673$128,500,0002.86%
NEUMEIER POMA INVESTMENT COUNSEL LLC 646,530$39,231,0002.30%
Paulson & Co. 1,273,161$77,255,0001.85%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 212,112$12,871,0001.44%
Tygh Capital Management, Inc. 152,332$9,244,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,147,000$69,600,0001.24%
Rock Springs Capital Management LP 1,025,000$62,197,0001.23%
View complete list of PACIRA PHARMACEUTICALS INC shareholders